LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: The relapsing fever spirochete Borrelia miyamotoi resists complement-mediated killing by human serum.

    Teegler, Axel / Herzberger, Pia / Margos, Gabriele / Fingerle, Volker / Kraiczy, Peter

    Ticks and tick-borne diseases

    2014  Volume 5, Issue 6, Page(s) 898–901

    Abstract: Borrelia miyamotoi, a relapsing fever spirochete transmitted by ixodid ticks, is able to cause infections associated with systemic complaints, including malaise and fever, as well as meningoencephalitis in immunocompromised patients. In order to ... ...

    Abstract Borrelia miyamotoi, a relapsing fever spirochete transmitted by ixodid ticks, is able to cause infections associated with systemic complaints, including malaise and fever, as well as meningoencephalitis in immunocompromised patients. In order to elucidate immune evasion of previously difficult to cultivate B. miyamotoi, we have examined the ability of this newly emerging human pathogen to escape the complement system. Growth inhibition assays revealed that B. miyamotoi is strongly resistant to complement-mediated bacteriolysis. Investigating complement activation, we found that B. miyamotoi showed reduced deposition of components C3, C5, C7, C8, C9 as well as the membrane attack complex (MAC) on the borrelial surface. In addition, no aberrations in cell morphology were observed after incubation of B. miyamotoi in active human serum, confirming the findings of the growth inhibition assay. The data presented here provide strong evidence that B. miyamotoi overcome human complement by affecting the central complement component C3, thereby inhibiting formation of the C3 convertase and downstream activation of the complement cascade.
    MeSH term(s) Animals ; Borrelia/growth & development ; Borrelia/immunology ; Complement C3/immunology ; Humans ; Relapsing Fever/immunology ; Relapsing Fever/virology
    Chemical Substances Complement C3
    Language English
    Publishing date 2014-10
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2541872-5
    ISSN 1877-9603 ; 1877-959X
    ISSN (online) 1877-9603
    ISSN 1877-959X
    DOI 10.1016/j.ttbdis.2014.07.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: mRNA as a Novel Treatment Strategy for Hereditary Spastic Paraplegia Type 5.

    Hauser, Stefan / Poenisch, Marion / Schelling, Yvonne / Höflinger, Philip / Schuster, Stefanie / Teegler, Axel / Betten, Rabea / Gustafsson, Jan-Åke / Hübener-Schmid, Jeannette / Schlake, Thomas / Chevessier-Tünnesen, Frédéric / Horscroft, Nigel / Björkhem, Ingemar / Schöls, Ludger

    Molecular therapy. Methods & clinical development

    2019  Volume 15, Page(s) 359–370

    Abstract: Hereditary spastic paraplegia type 5 is a neurodegenerative disease caused by loss-of-function mutations in ... ...

    Abstract Hereditary spastic paraplegia type 5 is a neurodegenerative disease caused by loss-of-function mutations in the
    Language English
    Publishing date 2019-10-31
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2872938-9
    ISSN 2329-0501 ; 2329-0501
    ISSN (online) 2329-0501
    ISSN 2329-0501
    DOI 10.1016/j.omtm.2019.10.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top